People: Codexis Inc (CDXS.OQ)

CDXS.OQ on NASDAQ Stock Exchange Global Select Market

11:22pm IST
Change (% chg)

$-0.48 (-3.47%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Nicols, John 

Mr. John J. Nicols serves as President, Chief Executive Officer, Director of Codexis, Inc. Mr. Nicols brings to our board of directors his knowledge of Codexis as its President and Chief Executive Officer and his extensive prior management experience in the chemicals industry. Prior to that time, Mr. Nicols served in various capacities at Albemarle Corporation, a public company focused on the development, manufacture and marketing of highly engineered specialty chemicals, since he joined that company in 1990. Mr. Nicols most recently served as its Senior Vice President, Strategic Development and Catalysts, from March 2012 to June 2012. Mr. Nicols previously served as its Vice President, Catalysts from January 2007 to February 2012, its Vice President, Fine Chemistry from June 2002 to December 2006, its Division Vice President, Global Flame Retardants business from February 1999 through June 2002 and its Asia Pacific Business Director for the Bromine Chemicals business, based in Tokyo, Japan, from 1995 to 1998. Prior to his time with Albemarle Corporation, Mr. Nicols worked for three years in manufacturing and research and development for Hercules, Inc. Mr. Nicols has served on the board of directors of California Life Sciences Association (formerly BayBio), a non-profit organization, since January 2014. In addition, Mr. Nicols has served on the board of directors of Solve ME/CFS Initiative, a non-profit organization, since January 2015, and currently serves as chairperson and on the executive and nominating committees of that organization. Mr. Nicols received a B.S. in Chemical Engineering from the Polytechnic Institute of New York University and an M.B.A. from the Sloan School of Management at the Massachusetts Institute of Technology.

Basic Compensation

Total Annual Compensation, USD 1,141,330
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,297,480
Fiscal Year Total, USD 3,438,810

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 169,543 2,376,320.00
Name Fiscal Year Total

Bernard Kelley


John Nicols


Ross Taylor


Laurie Heilmann


Thomas Baruch


Pam Cheng

As Of  31 Dec 2018